Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med (2014) 4.76

Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer (2016) 2.91

ESR/ERS white paper on lung cancer screening. Eur Respir J (2015) 2.87

Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening. J Natl Cancer Inst (2015) 2.09

Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation Among Participants in the National Lung Screening Trial. JAMA Intern Med (2015) 1.92

Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Ann Intern Med (2015) 1.86

Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer (2014) 1.80

Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med (2014) 1.73

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. JAMA (2016) 1.56

National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med (2014) 1.56

Low-Dose CT Lung Cancer Screening Practices and Attitudes among Primary Care Providers at an Academic Medical Center. Cancer Epidemiol Biomarkers Prev (2015) 1.52

Trends in use and safety of image-guided transthoracic needle biopsies in patients with cancer. J Oncol Pract (2015) 1.45

Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med (2015) 1.17

Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst (2014) 1.15

Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res (2015) 1.11

Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest (2015) 1.11

Should CMS cover lung cancer screening for the fully informed patient? JAMA (2014) 1.09

Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care. JAMA Intern Med (2014) 1.08

Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010. PLoS One (2015) 1.04

Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods. Radiology (2015) 1.03

Noninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography. J Thorac Oncol (2014) 1.02

Health screening for older people-what are the current recommendations? Malays Fam Physician (2015) 0.98

Overdiagnosis in lung cancer screening: why modelling is essential. J Epidemiol Community Health (2015) 0.97

Primary Care Providers and a System Problem: A Qualitative Study of Clinicians Caring for Patients With Incidental Pulmonary Nodules. Chest (2015) 0.96

Attitudes and Beliefs of Primary Care Providers in New Mexico About Lung Cancer Screening Using Low-Dose Computed Tomography. Prev Chronic Dis (2015) 0.96

An Official American Thoracic Society/American College of Chest Physicians Policy Statement: Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in Clinical Practice. Am J Respir Crit Care Med (2015) 0.96

Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology. J Clin Oncol (2015) 0.95

Impact of provider-patient communication on cancer screening adherence: A systematic review. Prev Med (2016) 0.94

Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system. Cancer (2014) 0.90

Feasibility of a patient decision aid about lung cancer screening with low-dose computed tomography. Prev Med (2014) 0.90

Lung cancer screening with low-dose computed tomography for primary care providers. Prim Care (2014) 0.90

Tendons, Concentric Tubes, and a Bevel Tip: Three Steerable Robots in One Transoral Lung Access System. IEEE Int Conf Robot Autom (2015) 0.89

Cigarette smoking and cardiovascular events: role of inflammation and subclinical atherosclerosis from the MultiEthnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol (2015) 0.89

Lung cancer screening: history, current perspectives, and future directions. Arch Med Sci (2015) 0.86

Image-guided video assisted thoracoscopic surgery (iVATS) - phase I-II clinical trial. J Surg Oncol (2015) 0.86

Screening for lung cancer: moving into a new era. Ann Intern Med (2013) 0.85

Perceptions and Utilization of Lung Cancer Screening Among Primary Care Physicians. J Thorac Oncol (2016) 0.84

Complication rates of CT-guided transthoracic lung biopsy: meta-analysis. Eur Radiol (2016) 0.84

Trends in Subpopulations at High Risk for Lung Cancer. J Thorac Oncol (2016) 0.83

Lung cancer stigma as a barrier to medical help-seeking behavior: Practice implications. J Am Assoc Nurse Pract (2015) 0.83

Comparison of Smoking History Patterns Among African American and White Cohorts in the United States Born 1890 to 1990. Nicotine Tob Res (2016) 0.83

Trends in the proportion of patients with lung cancer meeting screening criteria. JAMA (2015) 0.83

Is surgery still the optimal treatment for stage I non-small cell lung cancer? Transl Lung Cancer Res (2016) 0.83

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada. PLoS Med (2017) 0.83

Geographic variation in radiologist capacity and widespread implementation of lung cancer CT screening. J Med Screen (2014) 0.82

Beyond Traditional Newspaper Advertisement: Leveraging Facebook-Targeted Advertisement to Recruit Long-Term Smokers for Research. J Med Internet Res (2016) 0.82

Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era: 1997-2012. AIDS (2016) 0.82

Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium. Clin Proteomics (2015) 0.82

High-risk older smokers' perceptions, attitudes, and beliefs about lung cancer screening. Cancer Med (2016) 0.81

Development and validation of a personalized, web-based decision aid for lung cancer screening using mixed methods: a study protocol. JMIR Res Protoc (2014) 0.81

Urinary protein biomarkers in the early detection of lung cancer. Cancer Prev Res (Phila) (2014) 0.81

Challenges With Identifying Indication for Examination in Breast Imaging as a Key Clinical Attribute in Practice, Research, and Policy. J Am Coll Radiol (2016) 0.81

Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada. J Thorac Oncol (2014) 0.81

Are cancer-related decision aids appropriate for socially disadvantaged patients? A systematic review of US randomized controlled trials. BMC Med Inform Decis Mak (2016) 0.81

Should Never-Smokers at Increased Risk for Lung Cancer Be Screened? J Thorac Oncol (2015) 0.81

Readiness of primary care clinicians to implement lung cancer screening programs. Prev Med Rep (2015) 0.80

SEOM guide to primary and secondary prevention of cancer: 2014. Clin Transl Oncol (2014) 0.80

Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen. Eur Radiol (2016) 0.80

ESR/ERS white paper on lung cancer screening. Eur Radiol (2015) 0.80

Targeted Cancer Screening in Average-Risk Individuals. Am J Prev Med (2015) 0.79

Analysis of Lung Flute-collected Sputum for Lung Cancer Diagnosis. Biomark Insights (2015) 0.79

Prognostic utility of coronary artery calcium scoring in active smokers: a 15-year follow-up study. Int J Cardiol (2014) 0.79

Buccal microRNA dysregulation in lung field carcinogenesis: gender-specific implications. Int J Oncol (2014) 0.79

Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention. Cancers (Basel) (2014) 0.79

Imaging-based screening: maximizing benefits and minimizing harms. Clin Imaging (2015) 0.79

Distress and patient-centered communication among veterans with incidental (not screen-detected) pulmonary nodules. A cohort study. Ann Am Thorac Soc (2015) 0.79

Patient Perspectives on Low-Dose Computed Tomography for Lung Cancer Screening, New Mexico, 2014. Prev Chronic Dis (2016) 0.78

Disparities in Cancer Incidence, Stage, and Mortality at Boston Health Care for the Homeless Program. Am J Prev Med (2015) 0.78

'I still don't know diddly': a longitudinal qualitative study of patients' knowledge and distress while undergoing evaluation of incidental pulmonary nodules. NPJ Prim Care Respir Med (2015) 0.78

Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial. Oncologist (2015) 0.78

Assessing the benefits and harms of low-dose computed tomography screening for lung cancer. Lung Cancer Manag (2015) 0.78

Predictors of imaging surveillance for surgically treated early-stage lung cancer. Ann Thorac Surg (2014) 0.78

Prevalence and significance of incidentally noted dilation of the ascending aorta on routine chest computed tomography in older patients. J Comput Assist Tomogr (2015) 0.78

Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication. Health Expect (2016) 0.78

Augmented meaningful use criteria to identify patients eligible for lung cancer screening. Ann Thorac Surg (2014) 0.78

Defining and measuring adherence to cancer screening. J Med Screen (2016) 0.78

Society of Behavioral Medicine supports implementation of high quality lung cancer screening in high-risk populations. Transl Behav Med (2016) 0.78

Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis. J Thorac Imaging (2015) 0.77

The performance of NLST screening criteria in Asian lung cancer patients. BMC Cancer (2015) 0.77

Early detection of lung cancer. F1000Res (2016) 0.77

Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC). J Radiat Oncol (2016) 0.77

How Patients View Lung Cancer Screening. The Role of Uncertainty in Medical Decision Making. Ann Am Thorac Soc (2016) 0.77

Results of the national lung cancer screening trial: where are we now? Thorac Surg Clin (2015) 0.77

Affective science perspectives on cancer control: strategically crafting a mutually beneficial research agenda. Perspect Psychol Sci (2015) 0.77

Role of chest computed tomography in prevention of occupational respiratory disease: review of recent literature. Semin Respir Crit Care Med (2015) 0.77

Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis. Cancer (2015) 0.77

Electromagnetic navigation transthoracic needle aspiration for the diagnosis of pulmonary nodules: a safety and feasibility pilot study. J Thorac Dis (2016) 0.76

Lung cancer screening: subsequent evidences of national lung screening trial. Tuberc Respir Dis (Seoul) (2014) 0.76

Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics? PLoS One (2015) 0.76

Evaluating the impacts of screening and smoking cessation programmes on lung cancer in a high-burden region of the USA: a simulation modelling study. BMJ Open (2016) 0.75

Lung cancer screening in patients with chronic obstructive pulmonary disease. Ann Transl Med (2016) 0.75

Shared Medical Decision Making in Lung Cancer Screening: Experienced versus Descriptive Risk Formats. Med Decis Making (2015) 0.75

Risk of non-hematologic cancer in individuals with high-count monoclonal B-cell lymphocytosis. Leukemia (2015) 0.75

Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration. Curr Oncol (2016) 0.75

A brief measure of Smokers' knowledge of lung cancer screening with low-dose computed tomography. Prev Med Rep (2016) 0.75

Adult health checkup: Update on the Preventive Care Checklist Form©. Can Fam Physician (2016) 0.75

Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial. Br J Radiol (2016) 0.75

Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer (2016) 0.75

Factor Structure and Stability of Smoking-Related Health Beliefs in the National Lung Screening Trial. Nicotine Tob Res (2015) 0.75

Quantitative Computed Tomography Classification of Lung Nodules: Initial Comparison of 2- and 3-Dimensional Analysis. J Comput Assist Tomogr (2016) 0.75

Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 16.82

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 15.83

Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 11.96

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 8.14

Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 6.78

Screening for colorectal cancer: recommendation and rationale. Ann Intern Med (2002) 6.56

Screening for prostate cancer: recommendation and rationale. Ann Intern Med (2002) 6.04

Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 6.01

Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst (2007) 5.48

Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med (2011) 5.46

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med (2005) 5.24

Screening for breast cancer: recommendations and rationale. Ann Intern Med (2002) 4.90

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 4.74

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med (2005) 4.66

Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2003) 4.55

Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med (2004) 4.52

Screening for obesity in adults: recommendations and rationale. Ann Intern Med (2003) 4.10

Screening for depression: recommendations and rationale. Ann Intern Med (2002) 3.88

Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 3.73

Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 3.65

Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 3.64

Screening for abdominal aortic aneurysm: recommendation statement. Ann Intern Med (2005) 3.35

Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 3.27

Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 3.26

Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 3.11

Update on the methods of the U.S. Preventive Services Task Force: estimating certainty and magnitude of net benefit. Ann Intern Med (2007) 3.03

Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2016) 3.02

Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med (2002) 2.98

Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med (2002) 2.95

Behavioral counseling in primary care to promote physical activity: recommendation and rationale. Ann Intern Med (2002) 2.94

Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 2.93

Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med (2009) 2.86

Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2015) 2.73

Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.57

Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.53

Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 2.53

Screening for suicide risk in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.49

Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2007) 2.32

Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.20

Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2014) 2.16

Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 2.15

Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2009) 2.09

Behavioral and Pharmacotherapy Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2015) 2.08

Breast cancer screening: from science to recommendation. Radiology (2010) 2.06

Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2009) 2.04

Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2008) 2.03

Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 1.97

Aspirin for the primary prevention of cardiovascular events: recommendations and rationale. Am Fam Physician (2002) 1.95

Screening for High Blood Pressure in Adults: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2015) 1.94

Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.87

Screening for asymptomatic bacteriuria in adults: evidence for the U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2008) 1.85

Chemoprevention of breast cancer: recommendations and rationale. Ann Intern Med (2002) 1.84

Screening for coronary heart disease: recommendation statement. Ann Intern Med (2004) 1.84

Screening for hepatitis B virus infection in nonpregnant adolescents and adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.83

Screening for type 2 diabetes mellitus in adults: recommendations and rationale. Ann Intern Med (2003) 1.81

Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2007) 1.75

The effectiveness of primary care-based interventions to promote breastfeeding: systematic evidence review and meta-analysis for the US Preventive Services Task Force. Ann Fam Med (2004) 1.72

Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2007) 1.71

Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.70

Screening for intimate partner violence and abuse of elderly and vulnerable adults: U.S. preventive services task force recommendation statement. Ann Intern Med (2013) 1.68

Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 1.63

Behavioral counseling to prevent skin cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 1.60

Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2012) 1.58

Screening for testicular cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2011) 1.56

Screening for hepatitis C virus infection in adults: recommendation statement. Ann Intern Med (2004) 1.56

Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 1.55

Screening for developmental dysplasia of the hip: a systematic literature review for the US Preventive Services Task Force. Pediatrics (2006) 1.51

Screening for family and intimate partner violence: recommendation statement. Ann Fam Med (2004) 1.47

Primary care behavioral interventions to reduce illicit drug and nonmedical pharmaceutical use in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.47

Screening for hemochromatosis: recommendation statement. Ann Intern Med (2006) 1.44

Screening for suicide risk: recommendation and rationale. Ann Intern Med (2004) 1.40

Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development. Ann Intern Med (2007) 1.40

Lung cancer screening: recommendation statement. Ann Intern Med (2004) 1.38

Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 1.37

Peri-operative glycaemic control regimens for preventing surgical site infections in adults. Cochrane Database Syst Rev (2009) 1.36

Screening for thyroid disease: recommendation statement. Ann Intern Med (2004) 1.36

Reconsidering the criteria for evaluating proposed screening programs: reflections from 4 current and former members of the U.S. Preventive services task force. Epidemiol Rev (2011) 1.33

Screening for gonorrhea: recommendation statement. Ann Fam Med (2005) 1.31

Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med (2005) 1.31

Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 1.30

Screening for chlamydial infection: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 1.29

Screening for carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2007) 1.28

Screening for syphilis infection: recommendation statement. Ann Fam Med (2004) 1.27

Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med (2016) 1.27

Behavioral counseling interventions to promote a healthful diet and physical activity for cardiovascular disease prevention in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 1.26

Screening for asymptomatic bacteriuria in adults: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med (2008) 1.26

Screening for cognitive impairment in older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2014) 1.25

Screening for cervical cancer: recommendations and rationale. Am J Nurs (2003) 1.25

Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 1.25

Screening for ovarian cancer: recommendation statement. Ann Fam Med (2004) 1.24

Behavioral counseling in primary care to promote a healthy diet: recommendations and rationale. Am J Prev Med (2003) 1.22

Medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2013) 1.21